Rationale: Heterogeneity in the septic response has hindered efforts to understand pathophysiology and develop targeted therapies. Source of infection, with different causative organisms and temporal changes, might influence this heterogeneity.
Measurements and Main Results:
A substantial portion of the transcribed genome (18%) was differentially expressed compared with that of control subjects, independent of source of infection, with eukaryotic initiation factor 2 signaling being the most enriched canonical pathway. We identified two sepsis response signature (SRS) subgroups in fecal peritonitis associated with early mortality (P = 0.01; hazard ratio, 4.78). We defined gene sets predictive of SRS group, and serial sampling demonstrated that subgroup membership is dynamic during intensive care unit admission. We found that SRS is the major predictor of transcriptomic variation; a small number of genes (n = 263) were differentially regulated according to the source of infection, enriched for IFN signaling and antigen presentation. We define temporal changes in gene expression from disease onset involving phagosome formation as well as natural killer cell and IL-3 signaling.
Sepsis is the life-threatening organ dysfunction caused by a dysregulated host response to infection (1) . Therapeutic options remain limited despite extensive efforts to develop and refine treatment strategies (2) . New insights into pathophysiology and the development of targeted treatments appropriate for individual patients at specific stages of the illness are urgently required (3) . To be successful, this approach requires clearer understanding of heterogeneity in the sepsis response, in which proinflammatory and immunosuppressed states are dynamic and frequently coexist (4) . We recently identified distinct transcriptomic sepsis response signatures (SRSs) in peripheral blood leukocytes from patients with community-acquired pneumonia (CAP) that are informative for immune response states and outcome (5) . In particular, patients with SRS1 exhibit an immunosuppressed phenotype associated with higher early mortality, with features of endotoxin tolerance, T-cell exhaustion, and downregulation of HLA class II.
It is not yet known whether comparable SRSs are present in sepsis caused by other sources of infection. Additionally, the extent to which the source of infection contributes to heterogeneity in the transcriptomic response is unclear, although there is evidence that gene expression signatures can distinguish between gram-positive, gramnegative, and viral etiologies, and these signatures may be useful in the diagnosis of CAP (6) (7) (8) (9) (10) (11) (12) (13) . In fecal peritonitis (FP), sepsis is triggered by a polymicrobial infection within the peritoneal cavity, complicated by the release of damage-associated molecular patterns (DAMPs) and the effects of anesthesia (14) . Conversely, CAP is caused by specific bacterial or atypical pathogens, and it is commonly preceded or caused by viral infection (15) . Antibiotic choice, such as macrolides for CAP, may also have immunomodulatory effects (16, 17) . Finally, whereas patients with FP usually have a rapid onset of illness, patients with CAP are often unwell for many days prior to intensive care unit (ICU) admission.
FP is a common cause of sepsis with a high mortality (18) in which longitudinal analysis is tractable, given that a defined time of onset can be estimated. We hypothesized that SRSs similar to those seen in CAP would be present in patients with FP, but that aspects of the transcriptomic host response would be dependent on the source of infection and stage of illness. In the present study, we investigated how patterns of gene expression in leukocytes are influenced by source of infection in FP and CAP, as well as how they vary between individual patients and within patients over time. Some of the results of these studies were previously reported in the form of abstracts (19, 20) .
Methods Study Design and Participants
The objective was to characterize the transcriptomic response to sepsis caused by FP, including an analysis of temporal changes and a comparison with sepsis caused by CAP. The subjects were adult patients admitted to the ICU with sepsis as part of the UK Genomic Advances in Sepsis (GAinS) study (www.ukccg-gains.org) with predefined inclusion and exclusion criteria (described in the online supplement). FP was diagnosed at laparotomy as inflammation of the peritoneal membrane secondary to large bowel perforation and fecal contamination (18) . CAP was defined as a febrile illness associated with cough, sputum production, breathlessness, leukocytosis, and radiological features of pneumonia acquired in the community or within 2 days of ICU admission (21, 22) .
This was a prospective observational study. The transcriptomic response was investigated in peripheral blood leukocytes and compared between patients and over time, and with control subjects undergoing elective cardiac surgery (described in the online supplement). Discovery and validation cohorts were used to identify shared and specific gene expression patterns among patients with FP and patients with CAP (see Figure E1 in the online supplement).
Sample Collection
Blood samples (5 ml) were collected (VACUETTE ethylenediaminetetraacetic acid-coated tubes; Greiner Bio-One, Kremsmünster, Austria) on the first, third, and/or fifth day after ICU admission. The total blood leukocyte population was isolated using LeukoLOCK filters (Life Technologies, Carlsbad, CA) and then stabilized using RNAlater (Life Technologies), followed by total RNA extraction (described in the online supplement). Extensive, anonymized clinical information was recorded using an electronic case report form (5).
Microarray Analysis
Genome-wide gene expression was quantified using Illumina HumanHT-12 v4 Expression BeadChips (47,231 probes; Illumina, San Diego, CA) with sample processing, data preparation, background subtraction, transformation, and normalization using the vsn package (23) (described in the online supplement). Gene
At a Glance Commentary
Scientific Knowledge on the Subject: There is significant heterogeneity in the septic response, which has hindered efforts to understand pathophysiology and develop targeted therapies. Molecular approaches may provide insights into variation in the host response, enabling biomarker development. Recent evidence suggests that transcriptomic sepsis response signatures (SRSs) can define patient subgroups associated with early outcome in sepsis due to community-acquired pneumonia (CAP).
What This Study Adds to the
Field: This study provides the first substantive analysis of the transcriptomic response in patients admitted to intensive care with sepsis due to fecal peritonitis. Comparison with sepsis due to communityacquired pneumonia and with nonseptic control subjects demonstrated a shared sepsis response, independent of source of infection, that involved a significant proportion of the transcribed genome and overlapped with the "genomic storm" following trauma. We found evidence of SRS groups in patients with fecal peritonitis predictive of early mortality, with group membership changing over time in some patients. We show that the major predictor of variation in gene expression between patients with sepsis is SRS group rather than source of infection, with only a small number of genes differentially regulated according to the latter, enriched for IFN signaling and antigen presentation. These findings highlight opportunities for patient stratification in sepsis.
ORIGINAL ARTICLE expression data are available through the ArrayExpress database (accession number E-MTAB-5273/E-MTAB-5274).
Statistical Analysis
Analysis was performed using the R statistical software package (R Foundation for Statistical Computing, Vienna, Austria) unless otherwise specified, with statistical tests, power calculations, differential gene expression, enrichment testing, predictive modeling, and cluster analysis described in the online supplement.
Results

Transcriptomic Response to FP: Identification of SRSs
We quantified genome-wide gene expression for 117 adult patients with FP and 126 adult patients with CAP admitted to the ICU with sepsis, analyzing RNA from blood leukocytes rapidly isolated at the bedside. All patients showed evidence of organ dysfunction based on Sequential Organ Failure Assessment (SOFA) scores during ICU admission. These patients were recruited concurrently and processed in parallel as discovery (64 with FP, 73 with CAP) and validation cohorts (53 with FP, 53 with CAP; the 53 patients with CAP were previously published [5] ). We also analyzed samples obtained from 10 subjects prior to elective cardiac surgery as nonseptic control subjects in the discovery cohort. Demographics and clinical covariates for the discovery set (FP, n = 64 patients; CAP, n = 73 patients; 221 samples; see Figure E1 ) are shown in Tables 1 and E1A .
We investigated whether sepsis response subgroups based on global patterns of gene expression were present in FP. The combined FP cohort (147 samples from 117 patients) had a 28-day mortality of 13%; the mean age was 66 years, and 50.4% of patients were male ( Table 2, Table E1B ). We applied two complementary approaches to this FP cohort: (1) hypothesis-free unsupervised hierarchical clustering based on observed patterns of variation in gene expression and (2) assignment based on expression of a specific seven-gene set previously shown to be predictive of SRS group membership in CAP (5).
We first analyzed variation in global gene expression (2,716 probes representing the top 10% most variably expressed genes) using agglomerative hierarchical clustering followed by consolidation of group membership using k-means. This approach revealed two distinct patient groups: SRS1_FP (n = 68 [46%]) and SRS2_FP (n = 79 [54%]) ( Figures 1A and 1B) . Following group assignment, 1,075 genes were found to be differentially expressed between these groups ( Figure 1C , Table  E1C) , showing strong correlation with those previously observed in patients with CAP (5) (Pearson's r = 0.791) ( Figure E2 ).
To determine the functional overlap with SRS groups identified in CAP, we performed pathway, function enrichment, and upstream regulator analysis ( Figure 1D , Table E1D ). Cell death, apoptosis, necrosis, T-cell activation, and endotoxin tolerance were significantly enriched biological functions in SRS1 for both sources of infection. We proceeded to test for association with outcome in FP and found that SRS1_FP group membership was associated with higher early mortality (14-d mortality log-rank test P = 0.0096; 18.8% vs. 4.3%; hazard ratio, 4.78; 95% confidence interval, 1.29-17.65) ( Figure 1E ). The effect of SRS group membership remained after inclusion of age, SOFA score, Charlson comorbidity index, and sex in a Cox proportional hazards model (P = 0.037; hazard ratio, 4.23; 95% confidence interval, 1.09-16.39).
To further validate our findings, we adopted a second approach, namely assignment of SRS group membership in this FP cohort using the seven-gene set (DYRK2, CCNB1IP1, TDRD9, ZAP70, ARL14EP, MDC1, and ADGRE3) we previously established in patients with CAP (5) ( Figure E3 ). This showed strong concordance with the results obtained by unsupervised analysis (misclassification rate, 21.1%; area under the curve [AUC], 0.923) ( Figure 1F ). The groups defined using the seven-gene set showed a significant difference in early mortality rates (log-rank test P = 0.030 for patients with FP), a differential gene expression signature strongly correlated with that seen in the original CAP analysis (r = 0.845), as well as pathway enrichment comparable to findings in patients with CAP. We also derived a six-gene set (CD163, ZDHHC19, MME, FAM89A, ZBP1, and B3GNT2) from the FP data predictive of SRS_FP group membership, with a 4.1% misclassification rate based on internal leave-one-out crossvalidation (AUC, 0.975) ( Figure 1F ). When applied to the original CAP cohort (5), this six-gene set again performed well (misclassification rate, 27.9%; AUC, 0.931).
A poor outcome subgroup has previously been reported in children with sepsis (24) . We investigated the similarity between pediatric endotype A and SRS1 by comparative differential gene expression analysis. Although there was some overlap in pathway enrichment (e.g., T-and B-cell receptor signaling), the gene expression patterns that distinguish SRS groups were not enriched in the pediatric endotype contrast ( Figure E4 ).
Temporal Changes in SRSs
Serial sampling on Day 1, Day 3, and Day 5 following ICU admission provides the opportunity to investigate the relationship between SRS group membership and disease progression. We found that 11 (46%) of 24 patients with FP with serial samples moved between groups over time; 10 moved from SRS1 to SRS2, only 1 of whom died ( Figure 1G ). Thirteen patients (54%) remained in the same SRS group; three of seven patients remaining in SRS1 died, compared with no deaths among the six remaining in SRS2. This movement between SRS groups involves large changes in gene expression, illustrated by CD163, encoding an innate immune sensor for bacteria, and one of the six gene classifiers for SRS_FP (Figures 1H and E5 ).
Influence of Source of Infection on the Transcriptomic Response
We proceeded to further characterize and compare gene expression in patients with FP and patients with CAP to determine the relative importance of shared and specific features of the transcriptomic response. As expected, in the discovery cohort, gastrointestinal comorbidities were more common in patients with FP, whereas patients with CAP had more respiratory comorbidities, higher respiratory rates and oxygenation requirements, and higher lymphocyte counts (Table 1 and Table  E1A ). Although mortality did not differ significantly, patients with CAP had higher Acute Physiology and Chronic Healthy Evaluation II and SOFA scores than patients with FP (Table 1) .
To understand the relationships between source of infection, SRS group, and heterogeneity in the septic response, we performed principal component analysis using the top 10% most variably expressed transcripts. Nonseptic control subjects clustered together and were clearly distinct from septic patients (Figure 2A ). Among the combined population of patients with sepsis, there was clear segregation based on SRS group but not source of infection (Figure 2A) .
To further elucidate the drivers of variation in the septic response, we calculated correlations between the observed variance in global gene expression for the sepsis samples (the first six principal components of variance, representing approximately 50% of the variance in the Figure E6 ).
When we compared all patients in the discovery cohort (FP, n = 64; CAP, n = 73) with nonseptic control subjects (n = 10), we found that sepsis was associated with differential regulation of a large proportion of the transcribed genome (18.0% of transcripts assayed; 4,881 probes; .1.5-fold change [FC]; FDR, ,0.05) (Table E1F ). Pathway analysis showed that eukaryotic initiation factor 2 signaling was the top canonical pathway, consistent with the reported role for this translational initiation factor in response to viral and bacterial infection (25) , and predicted key upstream regulators IL-13, ATB1, TGFB1, and IL-2 (Table E1G) . We used the same methodology to compare gene expression in trauma patients with healthy subjects, using the previously published genomic response to trauma dataset (26) but restricting this to samples from the same time frame as the sepsis cohort (5 d following injury). We found that, of the genes differentially expressed in the sepsis response and measured in the trauma cohort, the majority (n = 1,884 [64%]) were also differentially expressed in trauma ( Figure 2C ). Commonality was seen with eukaryotic initiation factor 2 signaling and inflammation-related pathways enriched in both sepsis and trauma responses, whereas the inflammatory response to organismal injury was specific to trauma and tumor necrosis factor receptor 1 (TNFR1) signaling was specific to sepsis ( Figure 2C , Table E1H ).
When we compared patients with CAP versus control subjects and patients with FP versus control subjects, we observed that gene expression patterns were highly correlated, demonstrating that most sepsis response pathways are common and independent of source of infection ( Figures  2D, 3A , and 3B; Tables E1I and E1J). To further investigate differential gene expression between patients with sepsis due to FP or CAP, we compared the first available samples for each patient following ICU admission (FP, n = 64; CAP, n = 73). We found 310 probes (263 genes) differentially expressed between the two sources of infection (FC, .1.5; FDR, ,0.05) ( Figure 3C , Table E1K ), significantly more than expected by chance based on permutation analysis ( Figure E7 ). We noted significant differences in total and differential cell counts between CAP and FP. The inclusion of differential cell counts in the regression model had minimal influence, with a similar list of differentially regulated genes and FCs strongly correlated with the original analysis ( Figure E8 , Table E1K ). IFN signaling (P = 6.1 3 10 210 ) and antigen presentation (P = 1.6 3 10 28 ) were the most significant enriched canonical pathways, upregulated in patients with CAP compared with FP ( Figure 3D , Table E1L ). Enriched networks involved IFN-a/b and the antimicrobial/inflammatory response (P = 1 3 10 239 ) ( Figure 3E ). IFIT1, IFIT2, and IFIT3 (IFN-induced antiviral genes), BTN3A3 (major histocompatibility complex class I gene), IFIH1 (sensor of viral nucleic acids), and OAS2 (IFN-induced antiviral enzyme) were all upregulated in patients with CAP. IFNs, endotoxins, and TNF were found to be significant upstream regulators ( Figure 3D , Table E1L ).
We confirmed our findings in a validation set comprising 53 patients with FP and 53 patients with CAP prospectively recruited to the UK GAinS study ( Figure   E1 ). We found SRS group, source of infection, cell count, and day of sampling were strongly associated with the first six principal components of gene expression; genes differentially expressed between FP/CAP correlated with those found in the discovery cohort (Pearson's r = 0.83; P , 2.2 3 10 216 ) (Table E1M ). Pathway analysis demonstrated high concordance of enriched pathways and functions ( Figure 3D, Table E1N ). We found that a gene set comprising EPHB1, NQO2, ARG1, HMGB2, FGL2, and GPR162 was predictive of source of infection (FP or CAP) for the discovery cohort. We applied a sparse regression method to show that, for the discovery cohort, the misclassification rate was 29.9% with internal leave-one-out validation (AUC, 0.760); for the validation cohort, the test error was 28.3% (AUC, 0.798) ( Figure E9 ). There was no difference in the proportion of different sampling days following ICU admission between FP and CAP samples in the analyzed cohorts (chisquare P = 0.350) ( Figure E10 ).
Given a prominent viral signature among genes differentially expressed between patients with FP and patients with CAP, we investigated if this came from a subset of patients with CAP with a viral infection. Only 6 of 73 patients with CAP in the discovery cohort had a confirmed viral infection; we therefore analyzed the transcriptomic differences between patients with and without confirmed viral infection in our larger, previously published CAP cohort (25 vs. 240 patients) (5). We identified 39 differentially expressed genes (FDR, ,0.05; FC, .1.5) ( Figure 3F , Table  E1O ), including IFI27, an IFN-a-inducible protein reported as a marker of influenza infection (27) , and LAMP3, a dendritic cell glycoprotein induced by influenza A infection (28) . Pathway analysis showed the most significant enrichment for pattern recognition receptors, IFN signaling, and IFN regulatory factors (Table E1P) . We then compared this gene set to the genes differentially expressed between patients Figure 1 . (Continued). phenotypes, and predicted upstream regulators derived from differentially expressed probes in FP SRS groups and compared with the previously published community-acquired pneumonia (CAP) dataset. Enrichment was also seen for an endotoxin tolerance gene expression signature we previously defined (5) using publicly available datasets (42, 43) in SRS1_FP relative to SRS2_FP, tested using ROAST (rotation gene set testing), a gene set enrichment test (P , 1 3 10 
CAP Sepsis Response
Temporal Changes in Gene Expression
Interpretation of gene expression patterns in sepsis may be complicated by dynamic differences in the host response over time (10, 29) . We explored temporal changes in gene expression for patients with FP and patients with CAP from whom serial samples following ICU admission were available. We first sought to identify genes that varied over time using a repeated measures regression model. We found that 714 genes were significantly differentially expressed in patients with FP sepsis between Days 1 and 5, compared with only 80 genes in patients with CAP (FDR, ,0.05; FC, .1.5) ( Figure 4A , Table E1Q ). We further analyzed our data using a multivariate empirical Bayes model that ranks genes based on differential expression for longitudinal series involving multiple biological conditions (30) , restricting this analysis to patients from whom samples were available at all three time points. Notably, temporal changes in gene expression were again more pronounced in patients with FP (Table E1R) , and the specific genes whose expression changed over time differed between FP and CAP ( Figures 4B and C) . In patients with FP, it was possible to estimate with reasonable accuracy the time of onset of the acute event. We calculated days from disease onset for each FP sample and used this to investigate temporal changes. Using a linear model with limma analysis, we found that 140 genes showed significant changes in expression over time (FDR, ,0.05) (Table E1S) , including AAK1 and SNN ( Figure 4D ). Pathway analysis was significant for genes involved in phagosome formation; natural killer cell and IL-3 signaling with evidence of enrichment for specific biological functions, notably cellular degranulation, chemotaxis, leukocyte activation, macrophage adhesion, phagocytosis, and bacterial infection (Table E1T) .
Discussion
We have characterized the transcriptomic response to sepsis caused by FP and found evidence of SRSs associated with outcome, with patients in SRS1 having higher early mortality. Transcriptomic features of endotoxin tolerance and pathway enrichment for cell death, apoptosis, necrosis, and T-cell exhaustion are consistent with animal models and human studies demonstrating the importance of immune compromise in sepsis pathogenesis and as a determinant of poor outcomes (4, 31, 32) . The FP dataset allowed us to explore evolution of SRS membership. We found a significant number of patients (46%) switched SRS groups in the first 5 days of ICU admission, with the majority moving from SRS1 to SRS2. Persistence of SRS1 is associated with a poor outcome, whereas maintenance or recovery of immune competence (SRS2) is associated with survival. These findings further support the concept that SRS group membership reflects clinically important biological differences (5) and suggest that, if used as a biomarker, the transcriptomic response signature should be determined at the time a therapeutic intervention is being considered. Establishing the immune response state of a patient could enable individually tailored immunotherapy and monitoring of the response to treatment.
We found that the transcriptomic response is, to a large extent, shared between the two sources of infection we analyzed, with the expression of only a modest number of genes being dependent on source of infection. This shared sepsis response involves a significant proportion of the transcribed genome and overlapped with the "genomic storm" following trauma, although we observed some differences involving, for example, TNFR1 signaling (26) . Regarding gene expression between FP and CAP, the most enriched networks involved IFN-a/b and the antimicrobial/inflammatory response. These differences seem to be driven predominantly by viral respiratory infection within the CAP cohort; however, given current difficulties in pathogen detection, the biological and clinical interpretation of such transcriptomic differences remains challenging. Whereas some previous studies have supported a common transcriptional septic response independent of pathogen (33), others have reported that expression signatures can discriminate between infecting organisms (6) (7) (8) 13) , although these findings remain controversial (9, 10) . For patients admitted to the ICU with suspected CAP, a 78-transcript signature has been reported to differentiate cases of CAP from non-CAP, with the FAIM3: PLAC8 gene expression ratio proposed as a diagnostic biomarker (11) .
We found that temporal changes were more pronounced in patients with FP, with more than eight times as many genes differentially expressed between admission and Day 5 than in patients with CAP, and these changes involved phagosome formation, natural killer cell signaling, IL-3 signaling, leukocyte activation, mitochondrial damage, and apoptosis. To date, time series analyzing changes in gene expression have been focused on animal models of sepsis (34) , the endotoxin response in healthy volunteers (35) , the response to trauma and subsequent infection (26) , and early events in sepsis (29) , and authors of a recent analysis of timematched cohorts defined a gene set distinguishing sterile inflammation from infectious inflammation (12) . In general, clearer resolution of temporal differences is critical to resolving heterogeneity in observed sepsis responses within and between patients.
Future work should include comprehensive pathogen phenotyping, such as by using metagenomic sequencing, given the recognized high proportion of culturenegative patients with sepsis (36, 37) . Comparison of patients with FP with specific control subjects, such as a group of patients undergoing laparotomy for noninfectious indications, would control for the effects of damage-associated molecular pattern-mediated signaling due to the surgical procedure as well as any modulating influences on the transcriptome due to general anesthesia, whereas inclusion 
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of patients undergoing laparotomy for gastric or small bowel perforation would to some extent control for different pathogens. Differences in differential cell count are potential confounders in transcriptomic analysis (10) , and, although the results presented were robust to differential leukocyte count, cell-type-specific transcriptomic profiling will be important for future studies (38) . Defining the most robust and informative predictive gene set for SRS membership on the basis of transcriptomics requires prospective large-scale validation using an appropriate point-of-care test. We note that the current seven-gene set established in patients with CAP and validated in patients with FP is consistent with a key role for a dysfunctional immune response in sepsis. This predictive gene set includes genes involved in cell growth (DYRK2), cell cycle (CCNB1IP1), stem cell maintenance (TDRD9), and DNA damage (ADGRE3), consistent with the observed pathway enrichment (cell death, apoptosis, necrosis) and with immune response through lymphocyte activation (ZAP70), major histocompatibility complex class II export (ARL14EP), and myeloid cell interactions in immunity (MDC1). The lack of overlap with pediatric sepsis endotypes that we observed requires further validation and may reflect developmental differences impacting pathophysiology and host immune dysfunction (39, 40) .
We have addressed sepsis heterogeneity using a transcriptomic approach in patients with FP and patients with CAP, demonstrating a shared sepsis response with distinct SRS groups that are dynamic, reflect the underlying biological response, and are informative for prognosis. Our findings also provide some evidence for differential patterns of expression between CAP and FP, two of the most common causes of sepsis. Our analysis, coupled with recent advances in the field (3, 4, 11, 41 ), highlights the opportunity to develop novel therapeutic interventions that can be targeted and appropriately timed to individual patients on the basis of their transcriptomic signatures, providing opportunities for precision medicine in sepsis. n Author disclosures are available with the text of this article at www.atsjournals.org.
